These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 15823452

  • 1. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 2. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
    Wang H, Wan YX, Zhang QK.
    Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678
    [Abstract] [Full Text] [Related]

  • 3. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 4. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 5. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B, Liu DB, Zhang X, DU LL, Han CZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [Abstract] [Full Text] [Related]

  • 6. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y, Sakai H, Hayashi T, Kanetake H.
    Prostate; 2003 Feb 01; 54(2):125-32. PubMed ID: 12497585
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST.
    Br J Cancer; 2000 Nov 01; 83(10):1344-50. PubMed ID: 11044360
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May 01; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 9. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan 01; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec 01; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R.
    Cancer Epidemiol Biomarkers Prev; 2007 May 01; 16(5):1017-22. PubMed ID: 17507631
    [Abstract] [Full Text] [Related]

  • 12. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS, Tanriverdi F, Yilmaz MO, Ozcelik B, Unluhizarci K.
    Gynecol Endocrinol; 2008 Mar 01; 24(3):117-21. PubMed ID: 18335323
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy.
    Izycki T, Chyczewska E, Naumnik W, Talalaj J, Panek B, Ossolinska M.
    Exp Oncol; 2004 Dec 01; 26(4):316-9. PubMed ID: 15627066
    [Abstract] [Full Text] [Related]

  • 14. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 15. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D, Capuano G, Colao A, Pivonello R, Manguso F, Puzziello A, D'Agostino L.
    Clin Endocrinol (Oxf); 2003 Dec 15; 59(6):699-706. PubMed ID: 14974910
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun 15; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 17. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R.
    Prostate Cancer Prostatic Dis; 2005 Jun 15; 8(1):84-90. PubMed ID: 15775992
    [Abstract] [Full Text] [Related]

  • 18. The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer.
    Sohda M, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Masuda N, Kuwano H.
    Anticancer Res; 2004 Jun 15; 24(5A):3029-34. PubMed ID: 15517912
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov 15; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 20. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Lee SE.
    Asian J Androl; 2008 Mar 15; 10(2):207-13. PubMed ID: 18097534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.